Please join us for a #BPIAskTheExpert on "Purification Tools to Address Low Yield Challenges with Protein A for the Manufacturing of Bispecifics and Other Modern Antibody Designs." A record number of novel #mAbs, BsAb, and mAb fragments are entering clinical studies. #Manufacturing of these new modalities requires a robust downstream #purification process that produces high yield, purity, and productivity much like its mAb predecessor. Learn about a novel affinity #chromatography technology developed to address purification needs of modern engineered antibodies and mAb fragments. Date: Thurs., August 29th. Time: 11 AM ET. Featuring: Chiu Lau-Barre, Application Staff Scientist, Thermo Fisher Scientific. Register Now: https://lnkd.in/gRnY29qZ
BioProcess International
Informationsdienste
Boston, Massachusetts 23,830 followers
brought to you by Informa Connect
Über uns
BioProcess International™ is a monthly, controlled-circulation magazine devoted to the development, scale-up, and manufacture of biotherapeutics and biodiagnostics. Each issue provides the global industrial biotherapeutic community with up-to-date, peer-reviewed information detailing the business, politics, ethics, applications, products, and services required to successfully drive biopharmaceuticals, vaccines, and biodiagnostics through the development and manufacturing process. BPI is a business unit of Informa Connect https://informaconnect.com
- Website
-
http://www.bioprocessintl.com/
External link for BioProcess International
- Industrie
- Informationsdienste
- Größe des Unternehmens
- 11-50 Mitarbeiter
- Hauptsitz
- Boston, Massachusetts
- Typ
- Öffentliches Unternehmen
- Gegründet
- 2002
- Spezialitäten
- marketing, Biopharmaceutical, biotechnology, print, electronic, online, advertising programs, bioprocessing, vaccines, monoclonal antibodies, protein therapeutics, cell therapies, gene therapy, cell therapy, and biomanufacturing
Standorte
-
Primäre
2 International Place
Boston, Massachusetts 02110-2601, US
-
One Research Drive
Suite 400A
Westborough, MA 01581, US
-
119 Farringdon Road
London, UK EC1R 3DA, US
-
PO Box 70
Dexter, OR 97431, US
Employees at BioProcess International
Aktualisierungen
-
We recently had the pleasure of sitting down with Amir Hefni, CEO of Resolution Therapeutics, to discuss their incredible work in macrophage cell therapy. Resolution Therapeutics is developing a macrophage cell therapy product to treat patients at risk of liver decompensation, helping people to avoid the need for a liver transplant. Amir will be joining us at Cell and Gene Therapy International this September 23-26 at the Hynes Convention Centre, Boston, USA. Find out more about Cell and Gene Therapy International here: https://lnkd.in/d9nmdak #BioProcessInternational #CellandGeneTherapyInternational #Innovation
-
Please join us for a #BPIAskTheExpert on "Reliable Data, Reliable Products: Maintaining Data Integrity in Bioprocessing Workflows." In today's regulated #bioprocessing environments, maintaining #dataintegrity is critical for maintaining confidence in the development and #manufacture of your therapeutic. This #webinar will explore the principles of data integrity compliance, presenting best practices and technological solutions, such as the OsmoTECH® XT Single-Sample Micro-Osmometer, to help laboratories overcome these challenges and ensure reliable results, while meeting #regulatory requirements. Date: Tues., August 27th. Time: 11 AM ET. Featuring: Shweta Nair, Senior Product Manager, Biopharma, Advanced Instruments, LLC. Register Now: https://lnkd.in/gV9Vj6zE
Reliable Data, Reliable Products: Maintaining Data Integrity in Bioprocessing Workflows
bpi.bioprocessintl.com
-
Understand how to apply today's leading strategic approaches for cost-effective and scalable biologics manufacturing by attending the upcoming BioProcess International Conference & Exhibition, held September 23-26, 2024 in Boston. Our Manufacturing Strategy track gathers top biopharma experts to show you how to accelerate timelines, boost efficiency, and improve sustainability. Featured presentations include: Agility and Flexibility in Supply Chain Management: Harnessing Digital Innovation to Drive Rapid Response to Market Volatility and Unexpected Challenges Imara Charles Ph.D, VP, Process and Digital Excellence, Global Supply Chain at Bristol Myers Squibb Regulatory Science Perspective on Implementing Industry 4.0 James Coburn, Senior Advisor for Emerging Technologies at FDA’s Office of Counterterrorism and Emerging Threats at FDA When a Template isn't Templated: Bioprocessing in the World of Vaccines Chase Orsello, Global Head, Bioprocess Development at Sanofi Lessons Learned During the Commercialization of Casgevy™, the First CRISPR-Cas 9 Derived Therapy to be Commercially Approved Ciaran Brady, Vice President – Manufacturing Science and Technology (MS&T) at Vertex Pharmaceuticals Register your team to attend this year's event by this Friday, August 23 to save $400 per person. View the full agenda and register today at https://lnkd.in/eYg-uZrV #BPIevent #BiotechWeekBoston Informa Connect Life Sciences
-
-
🚀 Start Up Stories: Meet Eris Jordan, Vice President of Clinical and Medical Affairs at Aurion Biotech! 🚀 Aurion Biotech are a clinical-stage biotech company. They aim to restore vision to all who need it by developing a platform of innovative, accessible, and effective advanced therapies. Eris will be joining us at Cell and Gene Therapy International this September 23-26 at the Hynes Convention Centre, Boston, USA. Find out more about Cell and Gene Therapy International here: https://lnkd.in/d9nmdak Learn more about their journey and impact! #Innovation #Startup #CellandGene
-
The latest episode of the Voices of Biotech #podcast is here! This episode features Carol Houts, Chief Strategy Officer, Germfree and Josh Ludwig, Global Director, Commercial Operations, ScaleReady. Together, they discuss how #sustainability measures can increase patient care and access through decentralized #manufacturing models, which can reduce the time, space, and cost associated with producing #cellandgenetherapies and other modalities. Listen to the full episode here: https://lnkd.in/gnpNKDPa
Podcast: Sustainability is about health equity, says ScaleReady and Germfree
bioprocessintl.com
-
🚀 Start Up Stories: Meet David Howell M.S., PhD., President and CEO at Bondwell Technologies! 🚀 Bondwell Technologies is revolutionizing the field of biotech with their innovative biomaterial-based platform technology. David will be joining us at BioProcess International this September 23-26 at the Hynes Convention Centre, Boston, USA. Find out more about BioProcess International here: https://lnkd.in/dXzjV2w Learn more about their journey and impact! #Innovation #Startup #BioProcessInternational #Biopharma
-
The next episode of the Voices of Biotech #podcast arrives on August 6th! In this episode, you can look forward to a conversation with Carol Houts, Chief Strategy Officer, Germfree & Josh Ludwig, Global Director, Commercial Operations, ScaleReady, as they speak with editor, Millie Nelson, about the latest in the industry. Listen to previous episodes here: https://lnkd.in/gnHuwkaW
-
-
Enjoy this #eBook titled, "Drug Delivery — New Formats for Novel Biopharmaceuticals." Emerging formulations and product modalities are raising new technical challenges for #biopharma formulation/fill–finish teams. Learn more about those challenges in BPI’s recent eBook on #drugdelivery, which includes discussion from Vincenza Pironti, Ph.D., MBA, Recipharm, about developments in final-product container systems and a conversation with Kurt Ristroph, Purdue University, about difficulties with formulating #mRNA into lipid nanoparticles. Read the full eBook here: https://lnkd.in/e8iG7vWd
Drug Delivery: New Formats for Novel Biopharmaceuticals
bioprocessintl.com
-
Please join us for a #BPIAskTheExpert on "More Product Faster: Maximize mAbs, Cell Therapy, and Gene Therapy Production with Upstream Process Intensification." This webinar from one of Repligen's expert application scientists dives into the role of #upstream #processintensification in scaling up productivity without compromising quality. Through real-world case studies, we will explore how Repligen's cutting-edge XCell® ATF System and KrosFlo® TFDF® System are revolutionizing upstream applications like N-1 perfusion, N perfusion and high-cell density transfection/infection processes focused on mAbs, AAV, LV, T cells, and other modalities. Date: Thurs., July 25th. Time: 11 AM ET. Featuring: Charles Hill, Senior Field Application Scientist, Upstream, Repligen Corporation. Register Now: https://lnkd.in/gvn-Efgz
More Product Faster: Maximize mAbs, Cell Therapy, and Gene Therapy Production with Upstream Process Intensification
bpi.bioprocessintl.com